Capstone Financial Advisors, Inc. Pfizer Inc Transaction History

Capstone Financial Advisors, Inc.

$1.62 Billion
Q3 2024

A detailed history of Capstone Financial Advisors, Inc. transactions in Pfizer Inc stock. As of the latest transaction made, Capstone Financial Advisors, Inc. holds 9,947 shares of PFE stock, worth $264,789. This represents 0.02% of its overall portfolio holdings.

Number of Shares

9,947

Previous 9,924 0.23%

Holding current value

$264,789

Previous $277,000 3.61%

% of portfolio

0.02%

Previous 0.02%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$27.7 - $31.39 $637 - $721	23 Added 0.23%	9,947 $287,000
Q2 2024 Aug 13, 2024	SELL	$25.26 - $29.6 $1,566 - $1,835	-62 Reduced 0.62%	9,924 $277,000
Q1 2024 May 14, 2024	SELL	$25.89 - $29.73 $85,566 - $98,257	-3,305 Reduced 24.87%	9,986 $277,000
Q4 2023 Feb 13, 2024	BUY	$26.13 - $33.94 $1,123 - $1,459	43 Added 0.32%	13,291 $382,000
Q3 2023 Nov 13, 2023	BUY	$32.09 - $37.51 $64,051 - $74,869	1,996 Added 17.74%	13,248 $439,000
Q2 2023 Aug 14, 2023	BUY	$36.12 - $41.79 $29,835 - $34,518	826 Added 7.92%	11,252 $412,000
Q1 2023 May 12, 2023	SELL	$39.39 - $51.28 $46,401 - $60,407	-1,178 Reduced 10.15%	10,426 $425,000
Q4 2022 Feb 15, 2023	SELL	$41.75 - $54.5 $20,207 - $26,378	-484 Reduced 4.0%	11,604 $594,000
Q3 2022 Nov 14, 2022	BUY	$43.76 - $53.42 $21,442 - $26,175	490 Added 4.22%	12,088 $529,000
Q2 2022 Sep 02, 2022	SELL	$46.53 - $55.17 $3,768 - $4,468	-81 Reduced 0.69%	11,598 $608,000
Q1 2022 May 13, 2022	BUY	$45.75 - $56.69 $7,548 - $9,353	165 Added 1.43%	11,679 $605,000
Q4 2021 Feb 11, 2022	BUY	$41.32 - $61.25 $8,470 - $12,556	205 Added 1.81%	11,514 $680,000
Q3 2021 Nov 15, 2021	BUY	$39.25 - $50.42 $12,599 - $16,184	321 Added 2.92%	11,309 $486,000
Q2 2021 Aug 16, 2021	BUY	$35.91 - $40.68 $47,544 - $53,860	1,324 Added 13.7%	10,988 $430,000
Q1 2021 May 13, 2021	SELL	$33.49 - $37.77 $151,743 - $171,135	-4,531 Reduced 31.92%	9,664 $350,000
Q4 2020 Feb 16, 2021	BUY	$33.47 - $42.56 $38,758 - $49,284	1,158 Added 8.88%	14,195 $523,000
Q3 2020 Nov 13, 2020	BUY	$31.75 - $37.25 $153,352 - $179,917	4,830 Added 58.85%	13,037 $478,000
Q1 2020 May 14, 2020	SELL	$27.03 - $38.62 $27,381 - $39,122	-1,013 Reduced 10.99%	8,207 $268,000
Q4 2019 Feb 14, 2020	BUY	$32.92 - $37.36 $59,519 - $67,546	1,808 Added 24.39%	9,220 $361,000
Q3 2019 Nov 13, 2019	SELL	$32.49 - $42.13 $3,086 - $4,002	-95 Reduced 1.27%	7,412 $266,000
Q2 2019 Aug 12, 2019	SELL	$36.98 - $41.52 $1,442 - $1,619	-39 Reduced 0.52%	7,507 $325,000
Q1 2019 May 14, 2019	BUY	$37.5 - $41.2 $16,125 - $17,716	430 Added 6.04%	7,546 $320,000
Q4 2018 Feb 14, 2019	BUY	$38.47 - $43.86 $38 - $43	1 Added 0.01%	7,116 $311,000
Q3 2018 Nov 20, 2018	BUY	$34.47 - $41.81 $34 - $41	1 Added 0.01%	7,115 $314,000
Q1 2018 May 15, 2018	SELL	$31.91 - $37.02 $1,595 - $1,851	-50 Reduced 0.7%	7,114 $252,000
Q4 2017 Feb 14, 2018	BUY	$33.26 - $35.29 $238,274 - $252,817	7,164	7,164 $259,000

Others Institutions Holding PFE

# of Institutions

3,260

Shares Held

3.61B

Call Options Held

77.2M

Put Options Held

122M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $149B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Capstone Financial Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Capstone Financial Advisors, Inc. with notifications on news.

Account

Capstone Financial Advisors, Inc. Pfizer Inc Transaction History